Cargando…
Sodium thiosulfate attenuates glial-mediated neuroinflammation in degenerative neurological diseases
BACKGROUND: Sodium thiosulfate (STS) is an industrial chemical which has also been approved for the treatment of certain rare medical conditions. These include cyanide poisoning and calciphylaxis in hemodialysis patients with end-stage kidney disease. Here, we investigated the anti-inflammatory acti...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4746933/ https://www.ncbi.nlm.nih.gov/pubmed/26856696 http://dx.doi.org/10.1186/s12974-016-0488-8 |
_version_ | 1782414897099833344 |
---|---|
author | Lee, Moonhee McGeer, Edith G. McGeer, Patrick L. |
author_facet | Lee, Moonhee McGeer, Edith G. McGeer, Patrick L. |
author_sort | Lee, Moonhee |
collection | PubMed |
description | BACKGROUND: Sodium thiosulfate (STS) is an industrial chemical which has also been approved for the treatment of certain rare medical conditions. These include cyanide poisoning and calciphylaxis in hemodialysis patients with end-stage kidney disease. Here, we investigated the anti-inflammatory activity of STS in our glial-mediated neuroinflammatory model. METHODS: Firstly, we measured glutathione (GSH) and hydrogen sulfide (H(2)S, SH(−)) levels in glial cells after treatment with sodium hydrosulfide (NaSH) or STS. We also measured released levels of tumor necrosis factor-α (TNFα) and interleukin-6 (IL-6) from them. We used two cell viability assays, MTT and lactate dehydrogenase (LDH) release assays, to investigate glial-mediated neurotoxicity and anti-inflammatory effects of NaSH or STS. We also employed Western blot to examine activation of intracellular inflammatory pathways. RESULTS: We found that STS increases H(2)S and GSH expression in human microglia and astrocytes. When human microglia and astrocytes are activated by lipopolysaccharide (LPS)/interferon-γ (IFNγ) or IFNγ, they release materials that are toxic to differentiated SH-SY5Y cells. When the glial cells were treated with NaSH or STS, there was a significant enhancement of neuroprotection. The effect was concentration-dependent and incubation time-dependent. Such treatment reduced the release of TNFα and IL-6 and also attenuated activation of P38 MAPK and NFκB proteins. The compounds tested were not harmful when applied directly to all the cell types. CONCLUSIONS: Although NaSH was somewhat more powerful than STS in these in vitro assays, STS has already been approved as an orally available treatment. STS may therefore be a candidate for treating neurodegenerative disorders that have a prominent neuroinflammatory component. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12974-016-0488-8) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4746933 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-47469332016-02-10 Sodium thiosulfate attenuates glial-mediated neuroinflammation in degenerative neurological diseases Lee, Moonhee McGeer, Edith G. McGeer, Patrick L. J Neuroinflammation Research BACKGROUND: Sodium thiosulfate (STS) is an industrial chemical which has also been approved for the treatment of certain rare medical conditions. These include cyanide poisoning and calciphylaxis in hemodialysis patients with end-stage kidney disease. Here, we investigated the anti-inflammatory activity of STS in our glial-mediated neuroinflammatory model. METHODS: Firstly, we measured glutathione (GSH) and hydrogen sulfide (H(2)S, SH(−)) levels in glial cells after treatment with sodium hydrosulfide (NaSH) or STS. We also measured released levels of tumor necrosis factor-α (TNFα) and interleukin-6 (IL-6) from them. We used two cell viability assays, MTT and lactate dehydrogenase (LDH) release assays, to investigate glial-mediated neurotoxicity and anti-inflammatory effects of NaSH or STS. We also employed Western blot to examine activation of intracellular inflammatory pathways. RESULTS: We found that STS increases H(2)S and GSH expression in human microglia and astrocytes. When human microglia and astrocytes are activated by lipopolysaccharide (LPS)/interferon-γ (IFNγ) or IFNγ, they release materials that are toxic to differentiated SH-SY5Y cells. When the glial cells were treated with NaSH or STS, there was a significant enhancement of neuroprotection. The effect was concentration-dependent and incubation time-dependent. Such treatment reduced the release of TNFα and IL-6 and also attenuated activation of P38 MAPK and NFκB proteins. The compounds tested were not harmful when applied directly to all the cell types. CONCLUSIONS: Although NaSH was somewhat more powerful than STS in these in vitro assays, STS has already been approved as an orally available treatment. STS may therefore be a candidate for treating neurodegenerative disorders that have a prominent neuroinflammatory component. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12974-016-0488-8) contains supplementary material, which is available to authorized users. BioMed Central 2016-02-08 /pmc/articles/PMC4746933/ /pubmed/26856696 http://dx.doi.org/10.1186/s12974-016-0488-8 Text en © Lee et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Lee, Moonhee McGeer, Edith G. McGeer, Patrick L. Sodium thiosulfate attenuates glial-mediated neuroinflammation in degenerative neurological diseases |
title | Sodium thiosulfate attenuates glial-mediated neuroinflammation in degenerative neurological diseases |
title_full | Sodium thiosulfate attenuates glial-mediated neuroinflammation in degenerative neurological diseases |
title_fullStr | Sodium thiosulfate attenuates glial-mediated neuroinflammation in degenerative neurological diseases |
title_full_unstemmed | Sodium thiosulfate attenuates glial-mediated neuroinflammation in degenerative neurological diseases |
title_short | Sodium thiosulfate attenuates glial-mediated neuroinflammation in degenerative neurological diseases |
title_sort | sodium thiosulfate attenuates glial-mediated neuroinflammation in degenerative neurological diseases |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4746933/ https://www.ncbi.nlm.nih.gov/pubmed/26856696 http://dx.doi.org/10.1186/s12974-016-0488-8 |
work_keys_str_mv | AT leemoonhee sodiumthiosulfateattenuatesglialmediatedneuroinflammationindegenerativeneurologicaldiseases AT mcgeeredithg sodiumthiosulfateattenuatesglialmediatedneuroinflammationindegenerativeneurologicaldiseases AT mcgeerpatrickl sodiumthiosulfateattenuatesglialmediatedneuroinflammationindegenerativeneurologicaldiseases |